Calendar Oramed Pharmaceuticals, Inc. Xetra
Stocks
OJU
US68403P1049
Biotechnology & Medical Research
|
End-of-day quote
Xetra
|
||
| - EUR | - |
|
| 08-31 | Lifeward Names Josh Hexter as Interim CEO and Rami Aviram as CFO | MT |
| 08-10 | Oramed Pharmaceuticals Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
Upcoming events on Oramed Pharmaceuticals, Inc.
| 2026-09-14 | Annual General Meeting |
Past events on Oramed Pharmaceuticals, Inc.
Past dividends on Oramed Pharmaceuticals, Inc.
| 2026-01-16 | Ex-dividend date for special dividend - 0.25 USD | 00:00 |
Annual results
| Fiscal Period | December | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 1,34 1,32 1.52% | 0,00 0,00 - | 2,00 2,00 0% | 0,00 |
|
EBITDA | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
|
EBIT Million USD | Released Forecast Spread | -15,8 -15,7 -0.15% | -12,8 -13,2 3.17% | -15,1 -12,4 -21.68% | -23,1 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 5,09 -10,2 149.86% | -15,9 -6,20 -156.77% | 75,3 65,6 14.82% | 248 |
|
Net income Million USD | Released Forecast Spread | 5,53 -12,8 143.15% | -19,1 -9,70 -96.49% | 64,1 54,0 18.61% | 189 |
|
EPS USD | Released Forecast Spread | 0,14 -0,32 144.44% | -0,48 -0,24 -100% | 1,50 1,29 16.28% | 4,47 |
| Announcement Date | 06/03/24 | 27/03/25 | 26/03/26 | - |
Quarterly results
| Fiscal Period | June | 2024 Q4 | 2025 Q1 | 2025 Q2 | 2025 Q3 | 2025 Q4 | 2026 Q1 | 2026 Q2 | 2026 Q3 | 2026 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 2,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 | 0,00 | |
|
EBIT Million USD | Released Forecast Spread | -3,60 -4,10 12.32% | -4,50 -3,60 -25% | -2,49 -4,50 44.69% | -2,43 -4,50 46.07% | -5,67 -3,00 -89.07% | -2,77 -2,60 -6.38% | -6,50 | -6,50 | |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -9,78 -0,10 -9683% | -7,06 -0,60 -1076.33% | 13,1 -1,50 975.6% | 59,5 -1,50 4063.4% | 9,80 0,00 - | 102 23,9 325.05% | 25,4 | 22,2 | |
|
Net income Million USD | Released Forecast Spread | -10,2 -0,90 -1032.11% | -7,64 -0,60 -1173.67% | 13,3 -1,50 985.87% | 48,4 -1,50 3326.33% | 10,0 0,00 - | 38,3 | 78,2 17,9 336.63% | 18,1 | 15,8 |
|
EPS USD | Released Forecast Spread | -0,26 -0,02 -1200% | -0,19 -0,01 -1800% | 0,31 -0,04 875% | 1,13 -0,04 2925% | 0,25 0,00 - | 0,91 | 1,84 0,43 327.91% | 0,43 | 0,37 |
| Announcement Date | 27/03/25 | 15/05/25 | 14/08/25 | 13/11/25 | 26/03/26 | 19/05/26 | 10/08/26 | - | - |
| 2026-09-03 |  | Information meeting | 20:01 |
| 2026-09-07 | | Earnings presentation | 21:00 |
| 2026-09-07 | | Significant Split/Dividend | 00:00 |
| 2026-09-07 | | Extraordinary General Meeting | |
| 2026-09-07 | | Annual General Meeting | |
| 2026-09-08 | | Information meeting | 07:00 |
| 2026-09-08 | | Présentation aux Actionnaires / Analystes | 17:00 |
| 2026-09-09 | | Earnings presentation | 04:30 |
| 2026-09-09 | | Extraordinary General Meeting | 22:00 |
| 2026-09-10 | | Extraordinary General Meeting | 02:30 |
Past sector events for Oramed Pharmaceuticals, Inc.
| 2026-09-02 | | Annual General Meeting | 13:00 |
| 2026-09-02 | | Présentation aux Actionnaires / Analystes | 13:00 |
| Today | | Présentation aux Actionnaires / Analystes | |
| 2026-08-31 | | Information meeting | 08:30 |
| 2026-08-30 | | Board of Directors Meeting | |
| 2026-08-30 | | Earnings release - Q2 2026 | |
| 2026-08-30 | | Board of Directors Meeting | |
| 2026-08-30 | | Earnings release - Q2 2026 | |
| 2026-08-29 | | Earnings release - Q2 2026 | 03:00 |
| 2026-08-29 | | Earnings release - Q2 2026 |
- Stock Market
- Stocks
- ORMP Stock
- OJU Stock
- Calendar Oramed Pharmaceuticals, Inc.
Select your edition
All financial news and data tailored to specific country editions
